Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk
Cheryl Ho, Jui‐Yi Chen(Chung Shan Medical University Hospital), Vin‐Cent Wu(National Taiwan University Hospital), Nai‐Wen Kang(Chi Mei Medical Center), Tzu-Hsuan Yeh(Chi Mei Medical Center), Min‐Hsiang Chuang(Chi Mei Medical Center), Wen-Wen Tsai(Chi Mei Medical Center), Hsien-Yi Wang(Chi Mei Medical Center), Heng‐Chih Pan(National Taiwan University)
Cited by 3
Related Papers
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
|Scientific Reports|2017|93
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
|International Journal of Molecular Sciences|2024|65
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
|Nature Communications|2024|65
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
|The Lancet Diabetes & Endocrinology|2025|53